Archive for September 2017

Bayers Halts Essure Sales Outside of U.S.

Essure Sales Halted

Bayer has announced that it will halt Essure sales in all markets with the exception of the United States. The female sterilization device has been linked to numerous instances of chronic pain, bleeding and other health problems, but Bayer insists that the decision is purely commercial, and is not ceasing sales due to medical or…

Read More

The Opioid Crisis: Who's Going to Pay?

opioid lawsuits

Lawsuits related to the opioid crisis have now begun to flood the U.S. court system. First were the suits filed by victims and their families, and the price tag for those was, is and will continue to be large. Those awards and settlements are quite likely to be dwarfed by the sums sought by states…

Read More

FDA Takes Steps to Curb Orphan Drugs

opioid lawsuits

FDA Commissioner Scott Gottlieb announced that he is taking steps to deal with abuses in the development of sorphan drugs by closing lucrative loopholes open to pharmaceutical companies. The Orphan Drug Act of 1983 provides incentives to research and produce drugs used to treat rare conditions. Incentives to produce drugs that be otherwise financially infeasible…

Read More

Victoza Lawsuit Settles for $58.65 Million

Novo Nordisk - Victoza

Novo Nordisk has settled eight whistleblower lawsuits involving Victoza, its top selling product. In agreeing to pay a total of $58.65 million the Danish drug manufacturer also resolved a probe by the U.S. Department of Justice. According to the allegations the company downplayed medical warnings, disguised salespeople as medical educators and paid kickbacks to doctors.…

Read More

Supreme Court Ruling Affects Drug Lawsuit Plaintiffs

Drug Lawsuits

A June Supreme Court ruling is likely to change significantly the opportunities available to prospective drug lawsuit plaintiffs. In an 8-1 ruling in BRISTOL-MYERS SQUIBB CO. v. SUPERIOR COURT OF CALIFORNIA, SAN FRANCISCO COUNTY, ET AL. the Supreme Court ruled that either the individual plaintiff or the defendant corporation must have a significant connection to the…

Read More